Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Taranabant> ?p ?o }
- Taranabant abstract "Taranabant (codenamed MK-0364) is a cannabinoid receptor type 1 inverse agonist that was investigated as a potential treatment for obesity due to its anorectic effects. It was discovered by Merck & Co.In October 2008, Merck has stopped its phase III clinical trials with the drugs due to high level of central side effects, mainly depression and anxiety.".
- Taranabant atcPrefix "A08".
- Taranabant atcSuffix "AX".
- Taranabant casNumber "701977-09-5".
- Taranabant fdaUniiCode "X9U622S114".
- Taranabant iupacName "N-[(2S,3S)-4-(4-chlorophenyl)-3-(3-cyanophenyl)-2-butanyl]-2-methyl-2-{[5-(trifluoromethyl)-2-pyridinyl]oxy}propanamide".
- Taranabant pubchem "11226090".
- Taranabant thumbnail Taranabant.png?width=300.
- Taranabant wikiPageID "16657658".
- Taranabant wikiPageLength "5290".
- Taranabant wikiPageOutDegree "19".
- Taranabant wikiPageRevisionID "697769877".
- Taranabant wikiPageWikiLink Anorectic.
- Taranabant wikiPageWikiLink Anxiety.
- Taranabant wikiPageWikiLink Cannabinoid_receptor_antagonist.
- Taranabant wikiPageWikiLink Cannabinoid_receptor_type_1.
- Taranabant wikiPageWikiLink Category:Amides.
- Taranabant wikiPageWikiLink Category:Anorectics.
- Taranabant wikiPageWikiLink Category:CB1_receptor_antagonists.
- Taranabant wikiPageWikiLink Category:Cannabinoids.
- Taranabant wikiPageWikiLink Category:Chloroarenes.
- Taranabant wikiPageWikiLink Category:Nitriles.
- Taranabant wikiPageWikiLink Category:Organofluorides.
- Taranabant wikiPageWikiLink Category:Pyridines.
- Taranabant wikiPageWikiLink Central_nervous_system.
- Taranabant wikiPageWikiLink Clinical_trial.
- Taranabant wikiPageWikiLink Depression_(mood).
- Taranabant wikiPageWikiLink Inverse_agonist.
- Taranabant wikiPageWikiLink Merck_&_Co..
- Taranabant wikiPageWikiLink Obesity.
- Taranabant wikiPageWikiLinkText "Taranabant".
- Taranabant wikiPageWikiLinkText "taranabant".
- Taranabant alt "Skeletal formula of taranabant".
- Taranabant alt "Space-filling model of the taranabant molecule".
- Taranabant atcPrefix "A08".
- Taranabant atcSuffix "AX".
- Taranabant c "27".
- Taranabant casNumber "701977".
- Taranabant chemspiderid "9401143".
- Taranabant cl "1".
- Taranabant f "3".
- Taranabant h "25".
- Taranabant image "Taranabant 3D spacefill.png".
- Taranabant inchi "1".
- Taranabant inchikey "QLYKJCMUNUWAGO-GAJHUEQPBS".
- Taranabant iupacName "N-[-4--3--2-butanyl]-2-methyl-2-{[5--2-pyridinyl]oxy}propanamide".
- Taranabant legalStatus "Investigational".
- Taranabant molecularWeight "515.95".
- Taranabant n "3".
- Taranabant o "2".
- Taranabant pubchem "11226090".
- Taranabant routesOfAdministration "Oral".
- Taranabant smiles "C[C@@H]NCCOC3=NC=CCF".
- Taranabant stdinchi "1".
- Taranabant stdinchikey "QLYKJCMUNUWAGO-GAJHUEQPSA-N".
- Taranabant unii "X9U622S114".
- Taranabant verifiedrevid "448081332".
- Taranabant watchedfields "changed".
- Taranabant width "250".
- Taranabant wikiPageUsesTemplate Template:Anorectics.
- Taranabant wikiPageUsesTemplate Template:Cannabinoid-stub.
- Taranabant wikiPageUsesTemplate Template:Cannabinoidergics.
- Taranabant wikiPageUsesTemplate Template:Cannabinoids.
- Taranabant wikiPageUsesTemplate Template:Cascite.
- Taranabant wikiPageUsesTemplate Template:Drugbankcite.
- Taranabant wikiPageUsesTemplate Template:Drugbox.
- Taranabant wikiPageUsesTemplate Template:Fdacite.
- Taranabant wikiPageUsesTemplate Template:Reflist.
- Taranabant subject Category:Amides.
- Taranabant subject Category:Anorectics.
- Taranabant subject Category:CB1_receptor_antagonists.
- Taranabant subject Category:Cannabinoids.
- Taranabant subject Category:Chloroarenes.
- Taranabant subject Category:Nitriles.
- Taranabant subject Category:Organofluorides.
- Taranabant subject Category:Pyridines.
- Taranabant hypernym Agonist.
- Taranabant type ChemicalSubstance.
- Taranabant type Drug.
- Taranabant type Group.
- Taranabant type Amide.
- Taranabant type Antagonist.
- Taranabant type Cannabinoid.
- Taranabant type Chemical.
- Taranabant type Drug.
- Taranabant type Group.
- Taranabant type Heterocycle.
- Taranabant type Nitrile.
- Taranabant type Organofluoride.
- Taranabant type Organohalide.
- Taranabant type Organofluoride.
- Taranabant type Organohalide.
- Taranabant type ChemicalObject.
- Taranabant type Thing.
- Taranabant type Q8386.
- Taranabant comment "Taranabant (codenamed MK-0364) is a cannabinoid receptor type 1 inverse agonist that was investigated as a potential treatment for obesity due to its anorectic effects. It was discovered by Merck & Co.In October 2008, Merck has stopped its phase III clinical trials with the drugs due to high level of central side effects, mainly depression and anxiety.".
- Taranabant label "Taranabant".
- Taranabant sameAs Q7685387.
- Taranabant sameAs Taranabant.
- Taranabant sameAs m.03yk5kn.